COL4A4 variant carriers also showed higher odds of hypertensive disease, consistent with nephritic syndrome commonly observed in Alport’s syndrome patients (MIM #203780), and lower hemoglobin concentrations and hematocrit percentage, consistent with hematuria (Fig. 6b). Here, COL4A4 is linked to hypertensive disorder.